肝门部胆管癌淋巴结廓清的争议与进展

王 之烁1, 王海 久*2
1、青海大学附属医院肝胆胰外科;青海大学研究生院
2、青海大学附属医院肝胆胰外科

摘要


肝门部胆管癌（hilar cholangiocarcinoma，HCCA）是一种高度恶性的肿瘤，近年来发病率呈上升趋势。对
于可切除疾病的患者，根治性切除术是肝门部胆管癌患者唯一可能治愈的治疗方法。肝门部胆管癌的预后通常较差，
准确的预后至关重要。淋巴结转移是肿瘤预后的重要指标。在文献中，有关肝门部胆管癌淋巴结清扫方面仍然存在
争议。目前，主要的争议点包括合理的淋巴结清扫范围、获取的最少淋巴结数量和最佳的预后评估指标。笔者基于
当前最新发表文献探讨这些争议，从而对肝门部胆管癌淋巴结廓清正确认识和理解，规范化肝门部胆管癌的淋巴结
清扫，改善患者预后。

关键词


肝门部胆管癌；淋巴结转移数；淋巴结转移率；阳性淋巴结对数比

全文:

PDF


参考


[1]中华医学会外科学分会胆道外科学组，解放军全

军肝胆外科专业委员会，肝门部胆管癌诊断和治疗指南

（2013版）[J].中华外科杂志，2013，51（10）：865-871.

[2]B X, W Z, J C, et al. - Comparative study on left_xfffe_sided versus right-sided hepatectomy for resectable [J]. World

J Surg Oncol, 2023, 21(1): 023-03037.

[3]FS D, M A, N S, et al. - Outcomes after Surgical

Resection of Hilar Cholangiocarcinoma [J]. J Coll Physicians

Surg Pak, 2019, 29(9): 874-7.

[4]B L, ID- ORCID X, Z L, et al. - Surgical treatment

of hilar cholangiocarcinoma: retrospective analysis [J]. BJS

Open, 2023, 7(3):

[5]HENG G, HUANG B, SHEN Y, et al. Vascular

invasion and lymph node metastasis mediate the effect of

CA242 on prognosis in hilar cholangiocarcinoma patients after

radical resection [J]. Frontiers in oncology, 2022, 12(1071439.

[ 6 ] G U A N J F , W A N G K . [ C u r r e n t s t a t u s

of intraoperative lymph node dissection for hilar

cholangiocarcinoma] [J]. Zhonghua wai ke za zhi [Chinese

journal of surgery], 2020, 58(1): 48-51.

[7]F G, F A, A G, et al. - Association of Lymph Node

Status With Survival in Patients After Liver Resection [J].

JAMA Surg, 2016, 151(10): 916-22.

[8]S C, A R, M S, et al. - What is the most accurate

lymph node staging method for perihilar [J]. European journal

of surgical oncology : the journal of the European Society

of Surgical Oncology and the British Association of Surgical

Oncology, 2017, 43(4): 743-50.

[9 ]DEOL IVE IRA M L, CUNN INGHAM S C,

CAMERON J L, et al. Cholangiocarcinoma: thirty-one_xfffe_year experience with 564 patients at a single institution [J].

Annals of surgery, 2007, 245(5): 755-62.

[10]SONG S C, CHOI D W, KOW A W, et al. Surgical

outcomes of 230 resected hilar cholangiocarcinoma in a single

centre [J]. ANZ journal of surgery, 2013, 83(4): 268-74.

[11]FURUSAWA N, KOBAYASHI A, YOKOYAMA

T, et al. Surgical treatment of 144 cases of hilar

cholangiocarcinoma without liver-related mortality [J]. World

journal of surgery, 2014, 38(5): 1164-76.

[12]International Union Against Cancer (UICC)

TNM classification of malignant tumours 7th ed Sobin

LH, Gospodarowicz MK, Wittekind C, editors Chichester:

Wiley-Blackwell; 2010,

[13]Amin MB, Edge S,Greene F, et al , American Joint

Committee on Cancer (AJCC) Cancer Staging Manual 8th ed

New York: Springer, 2017,

[14]周燕，刘宇，魏玲玲，et al.扩大淋巴结清扫对

腹腔镜下肝门胆管癌根治术患者临床预后的随访研究 [J].

中国医学前沿杂志（电子版），2021，13（10）：135-8.

[15]HAKEEM A R, MARANGONI G, CHAPMAN

S J, et al. Does the extent of lymphadenectomy, number of

lymph nodes, positive lymph node ratio and neutrophil_xfffe_lymphocyte ratio impact surgical outcome of perihilar

cholangiocarcinoma? [J]. Eur J Gastroenterol Hepatol, 2014,

26(9): 1047-54.

[16]Y K, M N, J K, et al. - Lymph node metastasis

from hilar cholangiocarcinoma: audit of 110 patients who [J].

Annals of surgery, 2001, 233(3): 385-92.

[17 ]HE M, XU X, FENG H, et al. Regi o n al

lymphadenectomy vs. extended lymphadenectomy for hilar

cholangiocarcinoma (Relay-HC trial): study protocol for

a prospective, multicenter, randomized controlled trial [J].

Trials, 2019, 20(1): 528.

[18]BERGQUIST A, VON SETH E. Epidemiology

of cholangiocarcinoma [J]. Best practice & research Clinical

129

现代医学前沿 | 第2卷/第11期

Advances in Mordern Medical

gastroenterology, 2015, 29(2): 221-32.

[19]VALERO V, 3RD, COSGROVE D, HERMAN

J M, et al. Management of perihilar cholangiocarcinoma

in the era of multimodal therapy [J]. Expert review of

gastroenterology & hepatology, 2012, 6(4): 481-95.

[20]SCHWARZ R E, SMITH D D. Lymph node

dissection impact on staging and survival of extrahepatic

cholangiocarcinomas, based on U.S. population data [J]. J

Gastrointest Surg, 2007, 11(2): 158-65.

[21 ]MAO K, LIU J, SUN J, et al. Pattern s and

prognostic value of lymph node dissection for resected

perihilar cholangiocarcinoma [J]. Journal of gastroenterology

and hepatology, 2016, 31(2): 417-26.

[ 2 2 ] K A M B A K A M B A P , L I N E C K E R M ,

SLANKAMENAC K, et al. Lymph node dissection in

resectable perihilar cholangiocarcinoma: a systematic review

[J]. American journal of surgery, 2015, 210(4): 694-701.

[23]ROCHA F G, MATSUO K, BLUMGART L H, et

al. Hilar cholangiocarcinoma: the Memorial Sloan-Kettering

Cancer Center experience [J]. J Hepatobiliary Pancreat Sci,

2010, 17(4): 490-6.

[24]ITO K, ITO H, ALLEN P J, et al. Adequate lymph

node assessment for extrahepatic bile duct adenocarcinoma [J].

Annals of surgery, 2010, 251(4): 675-81.

[25]GIULIANTE F, ARDITO F, GUGLIELMI A,

et al. Association of Lymph Node Status With Survival in

Patients After Liver Resection for Hilar Cholangiocarcinoma

in an Italian Multicenter Analysis [J]. JAMA Surg, 2016,

151(10): 916-22.

[26]AOBA T, EBATA T, YOKOYAMA Y, et al.

Assessment of nodal status for perihilar cholangiocarcinoma:

location, number, or ratio of involved nodes [J]. Annals of

surgery, 2013, 257(4): 718-25.

[27]Edge S,Byrd D,Compton CC,et alAmerican Joint

Committee on Cancer（AJCC) Cancer Staging Manual7th

edNew York:Spring,2010,

[28]Amin MB, Edge S,Greene F, et al , American Joint

Committee on Cancer (AJCC) Cancer Staging Manual 8th ed

New York: Springer, 2017,

[29]BERTERO L, MASSA F, METOVIC J, et al.

Eighth Edition of the UICC Classification of Malignant

Tumours: an overview of the changes in the pathological

TNM classification criteria-What has changed and why? [J].

Virchows Arch, 2018, 472(4): 519-31.

[30]L B, ID O, F M, et al. - Eighth Edition of the

UICC Classification of Malignant Tumours: an overview of

[J]. Virchows Arch, 2018, 472(4): 519-31.

[31]SAKATA J, TAKIZAWA K, MIURA K, et al.

Rational Extent of Regional Lymphadenectomy and the

Prognostic Impact of the Number of Positive Lymph Nodes

for Perihilar Cholangiocarcinoma [J]. Annals of surgical

oncology, 2023, 30(7): 4306-17.

[32]LIU Z P, ZHANG Q Y, CHEN W Y, et al.

Evaluation of Four Lymph Node Classifications for the

Prediction of Survival in Hilar Cholangiocarcinoma [J]. J

Gastrointest Surg, 2022, 26(5): 1030-40.

[33]T A, T E, Y Y, et al. - Assessment of nodal status

for perihilar cholangiocarcinoma: location, number, or [J].

Annals of surgery, 2013, 257(4): 718-25.

[34]A G, A R, T C, et al. - Prognostic significance of

lymph node ratio after resection of peri-hilar [J]. Hpb, 2011,

13(4): 240-5.

[35]K M, J L, J S, et al. - Patterns and prognostic value

of lymph node dissection for resected perihilar [J]. Journal of

gastroenterology and hepatology, 2016, 31(2): 417-26.

[36 ]SPOLVERATO G, E JAZ A, KIM Y, et al.

Prognostic Performance of Different Lymph Node Staging

Systems After Curative Intent Resection for Gastric

Adenocarcinoma [J]. Annals of surgery, 2015, 262(6): 991-8.

[ 3 7 ] G U G L I E L M I A , R U Z Z E N E N T E A ,

BERTUZZO F, et al. Assessment of nodal status for perihilar

cholangiocarcinoma location, number, or ratio of involved

nodes [J]. Hepatobiliary surgery and nutrition, 2013, 2(5):

281-3.

[38]AURELLO P, PETRUCCIANI N, NIGRI G R, et

al. Log odds of positive lymph nodes (LODDS): what are their

role in the prognostic assessment of gastric adenocarcinoma? [J].

J Gastrointest Surg, 2014, 18(7): 1254-60.

[39]ZHOU R, ZHANG J, SUN H, et al. Comparison

of three lymph node classifications for survival prediction in

distant metastatic gastric cancer [J]. International journal of

surgery (London, England), 2016, 35(165-71.

[40]BAGANTE F, TRAN T, SPOLVERATO G, et al.

Perihilar Cholangiocarcinoma: Number of Nodes Examined

and Optimal Lymph Node Prognostic Scheme [J]. J Am Coll

Surg, 2016, 222(5): 750-9.e2.


Refbacks

  • 当前没有refback。